Drugs / DS-1123
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02690337 | Jan 2016 → Nov 2017 | cancer | Daiichi Sankyo | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DS-1123 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02690337 ↗ |
| Known as | DS-1123a | “Study of DS-1123a in Advanced Solid Tumours” NCT02690337 ↗ |
| Route | Intravenous | “starting intravenous (IV) dose of 0.1 mg/kg.” NCT02690337 ↗ |